Effects of denosumab on the periosteum in patients with postmenopausal osteoporosis

Trial Profile

Effects of denosumab on the periosteum in patients with postmenopausal osteoporosis

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 18 May 2014

At a glance

  • Drugs Denosumab (Primary)
  • Indications Postmenopausal osteoporosis
  • Focus Pharmacodynamics
  • Most Recent Events

    • 18 May 2014 New trial record
    • 05 Apr 2014 Interim results presented at the 2014 World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top